Clinical Trial Update: Evaluating the Role of Pregabalin in Reducing Opioid Requirement in Spinal Fusion Surgeries of Two or More Vertebrae [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pregabalin to reduce opioid requirements in spinal fusion surgeries (two or more vertebrae) was terminated; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Fusion
• Spinal Fusion Complications

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Spinal Fusion | Phase 3 | Status: TERMINATED | Results posted: 2018-10-10